BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18374892)

  • 1. Colorectal complications of external beam radiation versus brachytherapy for prostate cancer.
    Lesperance RN; Kjorstadt RJ; Halligan JB; Steele SR
    Am J Surg; 2008 May; 195(5):616-20; discussion 620. PubMed ID: 18374892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing of High-Dose-Rate Brachytherapy With External Beam Radiation Therapy in Patients With Intermediate- and High-Risk Localized Prostate Cancer and Its Effects on Toxicity and Quality of Life: A Randomized Controlled Trial (THEPCA).
    Choudhury M; Thomas SS; Cain A; Palvai S; Nageshwaran S; Zhang J; Hayden K; Cain A; Hoskin P; Ahmed I
    Int J Radiat Oncol Biol Phys; 2024 May; 119(1):90-99. PubMed ID: 38163520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate external beam radiotherapy combined with high-dose-rate brachytherapy: dose-volume parameters from deformably-registered plans correlate with late gastrointestinal complications.
    Moulton CR; House MJ; Lye V; Tang CI; Krawiec M; Joseph DJ; Denham JW; Ebert MA
    Radiat Oncol; 2016 Oct; 11(1):144. PubMed ID: 27799048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Systematic Post-QUANTEC Review of Tolerance Doses for Late Toxicity After Prostate Cancer Radiation Therapy.
    Olsson CE; Jackson A; Deasy JO; Thor M
    Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1514-1532. PubMed ID: 30125635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cs-131 prostate brachytherapy boost and effect of hydrogel rectal spacer on long-term patient-reported rectal bleeding and bowel quality of life.
    Abdelhakiem MK; Keller A; Bajpai RR; Smith RP; Beriwal S; Benoit R
    Brachytherapy; 2023; 22(6):808-821. PubMed ID: 37648596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difference in the rate of rectal complications following prostate brachytherapy based on the prostate-rectum distance and the prostate longitudinal length among early prostate cancer patients.
    Kang MH; Yu YD; Shin HS; Oh JJ; Park DS
    Korean J Urol; 2015 Sep; 56(9):637-43. PubMed ID: 26366276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of low-risk prostate cancer: a retrospective study with 477 patients comparing external beam radiotherapy and I-125 seeds brachytherapy in terms of biochemical control and late side effects.
    Moll M; Paschen C; Zaharie A; Berndl F; Goldner G
    Strahlenther Onkol; 2021 Feb; 197(2):118-123. PubMed ID: 32642874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External beam radiotherapy of prostate cancer with or without high dose-rate brachytherapy: the Norwegian experience with long-term urinary and bowel adverse effects.
    Wedde TB; Smaastuen MC; Vatne K; Schulz-Jaavall MB; Fosså SD; Lilleby WL
    Scand J Urol; 2023 Aug; 58():68-75. PubMed ID: 37644904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal dose-histogram effects in the context of dose-volume-constrained prostate radiation therapy: analysis of data from the RADAR prostate radiation therapy trial.
    Ebert MA; Foo K; Haworth A; Gulliford SL; Kennedy A; Joseph DJ; Denham JW
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):595-603. PubMed ID: 25596108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of Radiation Therapy in Patients With Prostate Cancer and Inflammatory Bowel Disease: A Systematic Review.
    Trotta M; Patel KR; Singh S; Verma V; Ryckman J
    Pract Radiat Oncol; 2023; 13(5):454-465. PubMed ID: 37100389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary Bladder Cancer After Prostate Cancer Treatment: An Age-matched Comparison Between Radiation and Surgery.
    Monda S; Pratsinis M; Lui H; Noel O; Chandrasekar T; Evans CP; Dall'Era MA
    Eur Urol Focus; 2023 Sep; ():. PubMed ID: 37722954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brachytherapy for high grade prostate cancer induces distinct changes in circulating CD4 and CD8 T cells - Implications for systemic control.
    Wang H; Mendez L; Morton G; Loblaw A; Chung HT; Cheung P; Mesci A; Escueta V; Petchiny TN; Huang X; White SD; Downes M; Vesprini D; Liu SK
    Radiother Oncol; 2024 Feb; 191():110077. PubMed ID: 38176656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of radiation-induced late rectal toxicity in prostate cancer treatment: a volumetric and dosimetric analysis.
    Spohn SKB; Radicioni G; Eisfelder M; Zamboglou C; Baltas D; Grosu AL; Sachpazidis I
    Front Oncol; 2024; 14():1371384. PubMed ID: 38737910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of rectal balloon spacer in patients with localized prostate cancer receiving external beam radiotherapy.
    Costa P; Vale J; Fonseca G; Costa A; Kos M
    Tech Innov Patient Support Radiat Oncol; 2024 Mar; 29():100237. PubMed ID: 38322778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late Toxicities of Prostate Radiotherapy: Can We Further SMARTen Up the Therapeutic Index?
    Safavi AH; Berlin A; Glicksman RM
    Eur Urol Focus; 2023 May; 9(3):414-418. PubMed ID: 37032280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation proctitis after iodine-125 low-dose-rate prostate brachytherapy utilizing SpaceOAR hydrogel.
    Morita M; Hiramatsu A; Nishimura K; Yanagida W; Nakamura S; Yamatoya J; Noguchi T; Tanabe M; Fukagai T; Lederer JL
    Int J Urol; 2024 Jun; ():. PubMed ID: 38822580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study.
    Heumann P; Aguado-Barrera ME; Avuzzi B; Azria D; Briers E; Bultijnck R; Choudhury A; De Ruysscher D; Farcy-Jacquet MP; Fonteyne V; Gómez Caamaño A; Helmbold I; Johnson K; Kerns SL; Lambrecht M; Lingard Z; Rancati T; Rosenstein BS; Sperk E; Paul Symonds R; Talbot C; Valdagni R; Vega A; Veldeman L; Ward T; Webb A; West CM; Chang-Claude J; Seibold P;
    Radiother Oncol; 2023 Jan; 178():109426. PubMed ID: 36442608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long term clinical toxicity of radiation therapy in prostate cancer patients with Inflammatory Bowel Disease.
    Gestaut MM; Swanson GP
    Rep Pract Oncol Radiother; 2017; 22(1):77-82. PubMed ID: 27920612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between gut microbial change and acute gastrointestinal toxicity in patients with prostate cancer receiving definitive radiation therapy.
    Jang BS; Chung MG; Lee DS
    Cancer Med; 2023 Nov; 12(22):20727-20735. PubMed ID: 37921267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rectal ulcer associated with lenvatinib 15 years after definitive radiotherapy for prostate cancer: A case report.
    Kawata Y; Watanabe K; Tokiya R; Miyaji Y; Shiotani A; Katsui K
    Oncol Lett; 2024 Jan; 27(1):6. PubMed ID: 38028175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.